Understanding how certain immune cells help heal the lungs after injury
Defining the Role of Regulatory T Cells in Resolution of Acute Lung Injury
This study is looking at how special immune cells called regulatory T cells help the lungs heal after injuries like pneumonia and ARDS, and it aims to find new ways to improve recovery for patients by understanding how these cells work during the healing process.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11000341 on NIH RePORTER |
What this research studies
This research investigates the role of regulatory T cells in the recovery process from acute lung injuries, such as those caused by pneumonia and acute respiratory distress syndrome (ARDS). It aims to uncover how these immune cells contribute to healing by analyzing their behavior and gene expression in lung tissue during recovery. By studying these cells in both experimental models and patients, the research seeks to identify potential therapeutic targets that could enhance lung healing and reduce complications. The approach includes advanced techniques like transcriptome profiling to understand the specific functions of these cells during the resolution phase of lung injury.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults who have experienced acute lung injuries or ARDS.
Not a fit: Patients with chronic lung conditions or those who have not experienced acute lung injuries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve recovery from acute lung injuries, potentially reducing morbidity and mortality associated with ARDS.
How similar studies have performed: Previous studies have shown promising results regarding the role of regulatory T cells in other types of tissue healing, suggesting that this approach may yield valuable insights.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Mock, Jason Robert — Univ of North Carolina Chapel Hill
- Study coordinator: Mock, Jason Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.